Skip to main content
Equibles

Swiss National Bank

Bank

Position in MBX — MBX Biosciences, Inc.

CIK 1582202 ZURICH, V8
Back to MBX Full portfolio

Position in MBX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$2,368,080
+$1,042,740 QoQ
Shares Held
42,900
-3.4% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 172 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MBX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. MBX ranks #103 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in MBX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,368,080 42,900
2026-03-31 $1,325,340 44,400